柴胡疏肝散治疗卒中后抑郁临床观察及对血浆5-ht的影响研究

《柴胡疏肝散治疗卒中后抑郁临床观察及对血浆5-ht的影响研究》由会员上传分享，免费在线阅读，更多相关内容在学术论文-天天文库。

1、分类号：学校代号：10471密级：学号：2010151柴胡疏肝散治疗卒中后抑郁临床观察及对血浆5-HT的影响研究作者姓名：董宁导师姓名：崔应麟学科专业：中医内科学学位类型：医学科学学位所属院部：第二临床医学院2013年4月30日河南中医学院2013届硕士研究生学位论文柴胡疏肝散治疗卒中后抑郁临床观察及对血浆5-HT的影响研究研究生姓名：董宁导师：崔应麟教授指导组成员：孟毅教授常学辉副教授关东升博士学科、专业：中医内科学所属院、系：第二临床医学院中国﹒郑州２０13年4月30日硕士学位论文原创性声明本人所呈交的硕士学位论文，是在导师崔应麟

2、教授的指导下，独立进行临床科学研究工作所取得的成果。除文中已特别加以注明引用的内容外，论文中不包含任何其他个人或集体已经发表或撰写过的研究成果。对本文的研究做出重要贡献的个人和集体，均已在文中以明确方式标明并致谢。本人完全意识到本声明的法律结果由本人承担。特此声明。论文作者（签名）：年月日硕士学位论文使用授权声明本人已完全了解河南中医学院有关保留、使用硕士学位论文的相关规定，同意学校保留或向国家有关部门、机构送交本学位论文的复印件和电子版，允许论文被查阅或借阅。本人授权河南中医学院可以将本论文的全部或部分内容编入有关数据库进行检索，可

3、以采用影印、缩印或其他复制手段保存、汇编本论文（注：保密论文在解密后适用本授权声明）。特此声明。论文作者（签名）：导师（签名）：年月日年月日目录摘要······································································································1Abstract·····················································································

4、···············3前言······································································································5对象与方法·······························································································71临床资料···········································

5、··················································72病例诊断标准·······················································································73病例选择标准·······················································································84研究方法························

6、·····································································95观察内容···························································································106疗效判定标准·····················································································117数据处理及统计

7、学分析·········································································118临床诊断及试验方案流程图·············································································11结果··································································································

8、··131基线资料分析·····················································································132两组HAMD评分疗效比